US › Healthcare

Innovative Eyewear Inc. (LUCY)

US · Healthcare · Medical Instruments & Supplies

$0.79-6.29%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$1.0M

Revenue YoY

+74.5%

Net profit

$-1.7M

EPS

$-0.26

EPS estimate

$-0.37

Net margin

-165.3%

EPS came in at -0.26 against a street estimate of -0.37 — a beat of 29.7%.

Key statistics

Market cap

$7.9M

Forward P/E

0.0

P/B

1.14

Book value

$1.08

EPS (TTM)

$-1.29

52-week high

$2.05

52-week low

$0.65

50-day MA

$0.86

200-day MA

$1.01

Beta

2.74

Analyst view

with an average price target of $3.00.

Shareholding

Insiders

13.93%

Institutions

8.27%

Largest institutional holders

Fund	Stake
Cetera Investment Advisers	6.71%
XTX Topco Ltd	0.48%
Citadel Advisors Llc	0.34%
KeyBank National Association	0.23%
Geode Capital Management, LLC	0.21%
HRT FINANCIAL LLC	0.15%
Jane Street Group LLC	0.14%
UBS Group AG	0.06%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Innovative Eyewear Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.